How should horizon scanning studies be reported? Developing a checklist of standard items

preprint OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-06 · read from full text

This paper studied how to standardize reporting for horizon-scanning studies in healthcare innovation, using a multidisciplinary working group at the NIHR Innovation Observatory. The authors adapted reporting items from PRISMA-ScR through four workshops, then performed internal validation on 17 eligible Innovation Observatory reports (2017–2024) using coverage scoring to refine a prototype checklist. They report a final 35-item checklist (28 mandatory, 7 optional) with four novel components, including interest holder description, a HIP-D/I scope framework, technology characteristics, and integration of the PESTLE framework. A major caveat is that external validation using Delphi with multidisciplinary experts and a scoping review is planned rather than completed. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 3,451 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Abstract

Introduction Horizon-scanning identifies weak signals of innovation to anticipate future developments, providing strategic value for healthcare decision-making. Unlike evidence synthesis, it addresses emerging and uncertain areas but lacks standardised reporting, limiting transparency, consistency, and impact. Inconsistent terminology and poorly described methods hinder comparability and uptake. This study aimed to develop a prototype reporting checklist and glossary to support structured, transparent, and reproducible reporting of horizon-scanning methods in healthcare innovation.

Methods

A multidisciplinary working group of horizon-scanning, evidence synthesis, and information specialists was convened at the NIHR Innovation Observatory, the UK national horizon-scanning center, in May 2024. Using PRISMA-ScR as a framework, four workshops were held to adapt relevant reporting items and build a prototype checklist. Internal validation was conducted on 17 eligible Innovation Observatory reports (2017–2024), with scoring to assess item coverage. Items were then refined, classified as mandatory or optional, and finalised through consensus.

Results

Of 46 outputs screened, 17 met inclusion criteria. Fifteen checklist items achieved ≥50% coverage; 20 scored <50%. The final 35-item checklist (31 single and 4 multi-part items) includes 28 mandatory and 7 optional items. Four novel components were introduced: interest holder description, HIP-D/I scope framework, technology characteristics, and integration of the PESTLE framework.

Discussion

and recommendations This is the first checklist to standardise reporting in health technology horizon-scanning. While this checklist prototype has been developed internally, external validation involving multidisciplinary experts via Delphi and a scoping review are planned. Its adoption can enhance transparency, reproducibility, and strategic impact, strengthening this methodological field. Competing Interest Statement The authors have declared no competing interest. Funding Statement This study/project is funded by the National Institute for Health and Care Research (NIHR) [NIHR IO/project reference HSRIC-2016-10009]. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced are available online in the Open Science Framework repository.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0